New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis Practice-based Recommendations

被引：52

作者：

Harausz, Elizabeth P. ^{[1
]}

Garcia-Prats, Anthony J. ^{[2
]}

Seddon, James A. ^{[3
]}

Schaaf, H. Simon ^{[2
]}

Hesseling, Anneke C. ^{[2
]}

Achar, Jay ^{[4
]}

Bernheimer, Jonathan ^{[5
]}

Cruz, Andrea T. ^{[6
]}

D'Ambrosio, Lia ^{[7
,8
]}

Detjen, Anne ^{[9
]}

Graham, Stephen M. ^{[10
,11
]}

Hughes, Jennifer ^{[5
]}

Jonckheere, Sylvie ^{[12
]}

Marais, Ben J. ^{[13
]}

Migliori, Giovanni Battista ^{[7
]}

McKenna, Lindsay ^{[14
]}

Skrahina, Alena ^{[15
]}

Tadolini, Marina ^{[16
]}

Wilson, Peyton ^{[17
]}

Furin, Jennifer ^{[18
]}

机构：

[1] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA

[2] Stellenbosch Univ, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Cape Town, South Africa

[3] Imperial Coll London, Ctr Int Child Hlth, London, England

[4] Medecins Sans Frontieres, Manson Unit, London, England

[5] Medecins Sans Frontieres, Khayelitsha, South Africa

[6] Baylor Coll Med, Houston, TX 77030 USA

[7] Salvatore Maugeri Fdn, Tradate, Italy

[8] Publ Hlth Consulting Grp, Lugano, Switzerland

[9] United Nations Childrens Fund, New York, NY USA

[10] Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia

[11] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia

[12] Medecins Sans Frontieres, Bombay, Maharashtra, India

[13] Univ Sydney, Childrens Hosp Westmead, Sydney, NSW, Australia

[14] Treatment Act Grp, HIV TB Project, New York, NY USA

[15] Republican Res & Pract Ctr Pulmonol & TB, Minsk, BELARUS

[16] Univ Bologna, Alma Mater Studiorum, Unit Infect Dis, Dept Med & Surg Sci, Bologna, Italy

[17] Boston Childrens Hosp, Dept Med, Boston, MA USA

[18] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷 / 10期

基金：

英国医学研究理事会;

关键词：

multidrug-resistant tuberculosis; Mycobacterium tuberculosis; child; adolescent; pediatric; COMPASSIONATE USE; CHILDREN; BEDAQUILINE; DELAMANID; REGIMEN; TOLERABILITY; PROLONGATION; EXPERIENCE; MANAGEMENT; NEVIRAPINE;

D O I：

10.1164/rccm.201606-1227CI

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

It is estimated that 33,000 children develop multidrug-resistant tuberculosis (MDR-TB) each year. In spite of these numbers, children and adolescents have limited access to the new and repurposed MDR-TB drugs. There is also little clinical guidance for the use of these drugs and for the shorter MDR-TB regimen in the pediatric population. This is despite the fact that these drugs and regimens are associated with improved interim outcomes and acceptable safety profiles in adults. This review fills a gap in the pediatric MDR-TB literature by providing practice-based recommendations for the use of the new (delamanid and bedaquiline) and repurposed (linezolid and clofazimine) MDR-TB drugs and the new shorter MDR-TB regimen in children and adolescents.

引用

页码：1300 / 1310

页数：11

共 50 条

[1] Challenges of using new and repurposed drugs for the treatment of multidrug-resistant tuberculosis in children
Schaaf, H. Simon
Garcia-Prats, Anthony J.
McKenna, Lindsay
Seddon, James A.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (03) : 233 - 244
[2] Multidrug-resistant tuberculosis infection and disease in children: a review of new and repurposed drugs
Huynh, Julie
Marais, Ben J.
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2019, 6 : 1 - 16
[3] New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
Leibert, Eric
Danckers, Mauricio
Rom, William N.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 597 - 602
[4] The need to accelerate access to new drugs for multidrug-resistant tuberculosis
Cox, Helen S.
Furin, Jennifer J.
Mitnick, Carole D.
Daniels, Colleen
Cox, Vivian
Goemaere, Eric
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2015, 93 (07) : 491 - 497
[5] Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They?
Bastard, Mathieu
Guglielmetti, Lorenzo
Huerga, Helena
Hayrapetyan, Armen
Khachatryan, Naira
Yegiazaryan, Lusine
Faqirzai, Jamil
Hovhannisyan, Lana
Varaine, Francis
Hewison, Catherine
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (09) : 1228 - 1231
[6] Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine
Silvia Shinpei Chiang
Yana Sheremeta
Rachel Sophie Padilla
Helen Elizabeth Jenkins
Charles Robert Horsburgh
Vasyl Petrenko
Natasha Renee Rybak
Journal of Epidemiology and Global Health, 2019, 9 : 56 - 61
[7] Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine
Chiang, Silvia Shinpei
Sheremeta, Yana
Padilla, Rachel Sophie
Jenkins, Helen Elizabeth
Horsburgh, Charles Robert, Jr.
Petrenko, Vasyl
Rybak, Natasha Renee
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2019, 9 (01) : 56 - 61
[8] Novel treatments in multidrug-resistant tuberculosis
Mondoni, Michele
Saderi, Laura
Sotgiu, Giovanni
CURRENT OPINION IN PHARMACOLOGY, 2021, 59 : 103 - 115
[9] New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
Silva, Denise Rossato
Dalcolmo, Margareth
Tiberi, Simon
Arbex, Marcos Abdo
Munoz-Torrico, Marcela
Duarte, Raquel
D'Ambrosio, Lia
Visca, Dina
Rendon, Adrian
Gaga, Mina
Zumla, Alimuddin
Migliori, Giovanni Battista
JORNAL BRASILEIRO DE PNEUMOLOGIA, 2018, 44 (02) : 153 - 160
[10] Multidrug-resistant tuberculosis: current epidemiology, therapeutic regimens, new drugs
Gomez-Ayerbe, Cristina
Jesus Vivancos, Maria
Moreno, Santiago
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2016, 29 : 35 - 38

← 1 2 3 4 5 →